about
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trialVitamin D pathway gene variants and prostate cancer prognosisVasectomy and prostate cancer risk: a historical synopsis of undulating false causalityQuantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohortClinical utility of five genetic variants for predicting prostate cancer risk and mortality.Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Association of variants in estrogen-related pathway genes with prostate cancer risk.Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.A fully nonparametric estimator of the marginal survival function based on case-control clustered age-at-onset data.Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based studyRaman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cellsAssociation of hepsin gene variants with prostate cancer risk and prognosisAssociation of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.CYP17 polymorphisms and prostate cancer outcomes.Characterizing genetic risk at known prostate cancer susceptibility loci in African AmericansFamily-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locusVasectomy and risk of aggressive prostate cancer: a 24-year follow-up study.Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.Validation of genome-wide prostate cancer associations in men of African descent.Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control studyAMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.Circumcision and the risk of prostate cancer.The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community settingVasectomy and the risk of prostate cancer: a meta-analysis of cohort studies.The monoamine oxidase A gene promoter repeat and prostate cancer riskInvestigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descentHOXB13 mutations in a population-based, case-control study of prostate cancer.Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.The role of the BRCA2 gene in susceptibility to prostate cancer revisited
P2860
Q24594183-8542C0E4-17AF-49BF-87A6-194D74F2FDC3Q24628345-B40E743D-A505-421C-B267-F56E3135DCB8Q26739733-302750B2-3F7C-4286-9D18-7868DF43A912Q27302276-CD6888E5-6471-4D86-9919-73AADA5E65A9Q27323950-59AF638B-003A-42AF-90B3-E1C1BBD02240Q27331050-7B20266B-B339-4033-AF7A-928F38935543Q30492173-E2ADDB2C-F181-4C7F-8C9E-B4D5E3E83CD2Q30493284-01C35B7A-5D36-4C7C-93A5-80A80399B9DAQ30494721-189251F2-98C5-4FFD-9DEA-3FF73690ACDDQ30497028-22D5F263-E2BA-465A-8286-7463B63A443BQ30500998-A2BB8251-1707-466E-9B12-4573BE5D36E4Q30502672-AF808568-8DBB-42F5-B49D-34C08B8689FFQ30504100-83C2A03A-BF72-4E45-A811-0ECA3F2F26E8Q30532192-CE62286D-ED5B-4791-AB1D-4BA2B43020D2Q30582750-298F2A0B-162C-4EB9-B4FF-964D4163AB71Q31115963-BB7119FC-611E-4B8E-9EDB-5A8FE79843EDQ33359279-AF731142-F4D5-46A6-AA9A-85D92FEDE393Q33609681-ED8C935B-3BAF-4640-9E32-1521C9F271B8Q33762061-E7A2D15B-920B-439E-8F51-DC513E4EDA89Q33872480-8220B412-A207-4499-A3D8-3C5F73DFC94BQ33872530-856431B6-9F07-442A-9C6F-CF62FAB75661Q33884273-3E59C64B-E8BD-4948-B204-73A63FDA99ABQ33921139-C47B148C-E3DC-40C2-A134-2F7B6C04C342Q34112200-9F3E11DB-83D8-48CD-AEBE-B0C5D6C38878Q34172049-6B77B53D-E0AD-4BA9-8EAB-CD709EE05793Q34656524-AEEA62D2-3391-46F8-83B5-CEEAE0CEDFA7Q35032730-2F5E347C-E977-40E2-9232-08A9403C2154Q35089535-1A4BCB76-63A7-4754-955E-8B72C41844CDQ35143106-A7113330-BD9A-4BBD-89AA-23E6C6BC07D2Q35535396-2DDE04B6-E47B-4B3F-8296-515C9FD53B34Q36037214-F031DDF9-EC93-4E65-A9AE-9C94CD1A6C36Q36185925-65ACCC2A-C554-4D34-AF7F-A79C2DC2B14AQ36411680-E9A28334-4EBC-4E68-B062-895EE5B5D34DQ36495925-74FDF3D7-6617-4539-8083-B9E8DE89F802Q36496051-8C48563C-EE15-409D-BE7A-29CAE8274112Q36611191-1A9E2A35-F38A-406E-B30A-A131C5F8F29DQ36640906-A0B0AD4B-06C2-4C81-AE72-C110DA5EE3D5Q36728798-AC4F1F8A-301E-4AE7-B298-C39C738F024FQ36913512-7E85EBD1-3C9F-4516-935A-317BD0826C8DQ36924831-6424B43B-53BB-4259-AC12-6428A43BCAB7
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Vasectomy and risk of prostate cancer.
@en
type
label
Vasectomy and risk of prostate cancer.
@en
prefLabel
Vasectomy and risk of prostate cancer.
@en
P2093
P1476
Vasectomy and risk of prostate cancer
@en
P2093
McKnight B
Stanford JL
Wicklund KG
P304
P577
1999-10-01T00:00:00Z